ARTICLE | Clinical News
RSD-921 small molecule: Will begin Phase I trials in China and Brazil in the near future.
February 20, 1996 8:00 AM UTC
Nortran Pharmaceuticals Inc., Vancouver, B.C. Product: RSD-921 small molecule Indication: Cardiac arrhythmia Status: Will begin Phase I trials in China and Brazil in the near future. The company is ne...